KR101322337B1 - Silk artificial membrane for artificial dural membrane and biological membrane with excellent flexibility and solidity - Google Patents

Silk artificial membrane for artificial dural membrane and biological membrane with excellent flexibility and solidity Download PDF

Info

Publication number
KR101322337B1
KR101322337B1 KR20100133134A KR20100133134A KR101322337B1 KR 101322337 B1 KR101322337 B1 KR 101322337B1 KR 20100133134 A KR20100133134 A KR 20100133134A KR 20100133134 A KR20100133134 A KR 20100133134A KR 101322337 B1 KR101322337 B1 KR 101322337B1
Authority
KR
South Korea
Prior art keywords
artificial
silk
membrane
salt
present
Prior art date
Application number
KR20100133134A
Other languages
Korean (ko)
Other versions
KR20120071546A (en
Inventor
조유영
권해용
이광길
강석우
여주홍
우순옥
한상미
남성희
Original Assignee
대한민국
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대한민국 filed Critical 대한민국
Priority to KR20100133134A priority Critical patent/KR101322337B1/en
Priority to PCT/KR2011/009826 priority patent/WO2012086988A2/en
Publication of KR20120071546A publication Critical patent/KR20120071546A/en
Application granted granted Critical
Publication of KR101322337B1 publication Critical patent/KR101322337B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04HMAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/04Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres having existing or potential cohesive properties, e.g. natural fibres, prestretched or fibrillated artificial fibres
    • D04H1/08Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres from fleeces or layers composed of fibres having existing or potential cohesive properties, e.g. natural fibres, prestretched or fibrillated artificial fibres and hardened by felting; Felts or felted products
    • D04H1/09Silk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/32Materials or treatment for tissue regeneration for nerve reconstruction

Abstract

The present invention relates to a silk artificial membrane for artificial brain dural and biological membranes excellent in flexibility and suture strength, characterized in that consisting of silk fibroin and salt.
According to the present invention, the concern about the stability of the artificial membrane is avoided, the procedure and the treatment are easy because the flexibility and the bonding strength are excellent, and the thickness can be adjusted because the thick membrane of 300 µm or more can be produced.

Description

SILK ARTIFICIAL MEMBRANE FOR ARTIFICIAL DURAL MEMBRANE AND BIOLOGICAL MEMBRANE WITH EXCELLENT FLEXIBILITY AND SOLIDITY

The present invention relates to silk artificial membranes for artificial brain dural and biological membranes, and more particularly, to artificial membranes and artificial membranes for artificial membranes having excellent flexibility and susceptibility for easy treatment and treatment.

Covering the inner surface of the skull and projecting between the cerebral hemispheres and the cerebrum and cerebellum, between the brain and the pituitary gland inevitably damaged during brain surgery.

For this reason, the amount of artificial dura mater replacing the damaged dura mater is increasing, but a market of 1 trillion in the world and a market of 30 billion in Korea are formed.

Among the materials for the dura mater, human-derived dura mater is currently prohibited due to the high possibility of infection with Creutzfeldt-Jakob disease.

In recent years, artificial brain dural membranes prepared using animal (cow) -derived collagen have been used in clinical practice.

In Korean Patent Publication No. 10-100461475, a collagen material composed of a laminate in which a collagen ultrafine fibrous nonwoven multilayer body is sandwiched between non-fibrous collagen layers is used to remove defects of biological membranes such as the brain dura, pericardium, pleural cavity, peritoneum, or intestinal membrane. It is proposed to be used as a supplementary material.

Korean Patent Laid-Open Publication No. 10-2001-0052714 fills a matrix that is biocompatible and capable of being decomposed and absorbed in vivo in a matrix, which is a nonwoven polymorphic structure of collagen fibers based on collagen ultrafine fibers. Or synthetic collagen material, including artificial neural tube, artificial spinal cord, artificial esophagus, artificial organ, artificial blood vessel, artificial valve, artificial dura mater, artificial ligament, artificial ligament, artificial gun, surgical suture, surgical filler, surgical reinforcement material, It is proposed to be applied to wound protectors, artificial skin or artificial cornea.

However, the artificial brain dense produced using animal (cow) -derived collagen has a serious problem of susceptible infection such as mad cow disease.

Despite such serious defects, there is no substitute to replace artificial dura mater using animal-derived collagen. Currently, the artificial dural material using synthetic biomaterials, which are mainly developed, is mechanically secured such as biosafety and suture strength. It is not yet commercialized due to problems such as strength.

Korean Patent Publication No. 10-100461475 "Collagen material and its manufacturing method" Korean Laid-Open Patent Publication No. 10-2001-0052714 "Collagen material and its manufacturing method"

Disclosure of Invention An object of the present invention is to provide a silk artificial brain dura mater and a silk artificial membrane for biological membranes, which are excellent in flexibility and suture strength, and are easily treated and treated.

Silk artificial membrane of the present invention for achieving the above object includes silk fibroin and salt.

The silk artificial film of the present invention is preferably composed of 50.00 to 99.99% by weight of silk fibroin and 0.01 to 50.00% by weight of salt.

The salt is preferably used any one of calcium chloride, sodium chloride, potassium chloride, sodium acetate.

On the other hand, the method for producing a silk artificial film of the present invention comprises the step of mixing the mixture of 50.00 to 99.99% by weight of silk fibroin 0.01 to 50.00% by weight of salt to make a mixed solution and pouring the mixed solution into a flat container and dried to produce a silk artificial film .

In the drying step, it is preferable to dry the mixed solution contained in the container in a constant temperature room containing 20 ~ 80 ℃, 20 ~ 80% moisture.

According to the present invention, concerns about the stability of the artificial membrane are eliminated, and the flexibility is greatly enhanced, so that the procedure and the treatment are easy.

In addition, since a thick film of 300 µm or more can be produced, the thickness can be adjusted.

In addition, the procedure is easier because it is not only flexible but also transparent and has excellent suture strength.

In addition, there is no cytotoxicity, and it is waterproof to protect the spinal cord and prevent leakage of cerebrospinal fluid.

1 is a graph showing the elongation rate of the silk artificial brain dura as an example of the silk artificial membrane of the present invention.
2 is a cross-sectional and surface photographic view of the silk artificial brain dura as an example of the silk artificial membrane of the present invention.
Figure 3a is a photographic view showing the transparency of the silk artificial brain dura as an example of the silk artificial membrane of the present invention.
Figure 3b is a view showing the transparency of the artificial dura mater made from conventional proprietary collagen.
Figure 4 is a photographic view showing the flexibility of the silk artificial brain dura as an example of the silk artificial membrane of the present invention.
5 is a photographic view showing the suture strength of the silk artificial brain dura as an example of the silk artificial membrane of the present invention.
Figure 6a is a graph showing the cytotoxicity results of silk artificial brain dura, an example of the silk artificial membrane of the present invention in 24 hours culture.
Figure 6b is a graph showing the cytotoxicity results of silk artificial brain dura, an example of the silk artificial membrane of the present invention at 48 hours culture.
Figure 6c is a graph showing the cytotoxicity results of silk artificial brain dura, an example of the silk artificial membrane of the present invention in 72 hours culture.

Hereinafter, preferred embodiments of the present invention will be described.

The silk artificial membrane of this invention consists of silk fibroin and a salt.

Silk fibroin is a protein that, together with sericin, forms a cocoon (silk).

Silk fibroin is relatively evenly present in 18 amino acids. Unlike the keratin protein of wool fibers, silk fibroin has a high content of glycine and alanine.

Among the amino acids of the collagen protein, the major protein that constitutes the human skin, glycine and alanine are the most abundant in the fibroin protein.

The fibroin protein having an amino acid structure similar to that of human skin has excellent biocompatibility and exhibits no inflammatory effect.

For this reason, the silk artificial film of this invention which has silk fibroin as a main component can dispel the concern about stability.

Salt, which is another main component of the silk artificial film of the present invention, makes the silk artificial film of the present invention flexible by making flexible the stiff symptoms occurring when a thick film is made only with silk fibroin.

In addition, the salt increases the strength of the silk artificial membrane of the present invention.

In addition, the salt may be any salt-based material, it is preferable to use any one of calcium chloride, sodium chloride, potassium chloride, sodium acetate.

After all, the silk artificial membrane of the present invention is very easy to perform the procedure and treatment because of its excellent flexibility and strength, in particular, because it has a very good suture strength and further has a waterproof property to prevent the leakage of cerebrospinal fluid and protection of the spinal cord, It is very suitable for use as a silk artificial brain dura mater.

In addition, since the silk artificial membrane of the present invention has transparency, it enables safe treatment during surgery, and because it is safe to use, there is no cytotoxicity and thus there is no problem in using it as a biofilm widely.

In addition, since the silk artificial film of the present invention can have a thickness of 300 μm or more, the thickness can be adjusted.

Such a silk artificial film of the present invention is preferably composed of 50.00 to 99.99% by weight of silk fibroin, and 0.01 to 50.00% by weight of salt.

If the silk fibroin is less than 50.00% by weight, there is a problem in forming the film. If the silk fibroin is more than 99.99% by weight, the flexibility of the film is lowered. Therefore, the silk artificial film of the present invention preferably contains 50.00 to 99.9% by weight of silk fibroin.

In addition, if the salt is less than 0.01% by weight, there is a problem that the flexibility of the film is lowered. If the salt is more than 50.00% by weight, the silk fibroin has a problem of forming a film, and therefore, the silk artificial film of the present invention has a salt of 0.01 to 50.00% by weight. It is good to contain.

Such a silk artificial film of the present invention is prepared by mixing 0.01 to 50.00% by weight of a liquid salt with 50.00 to 99.99% by weight of liquid silk fibroin to make a mixed liquid, and pouring the mixed liquid into a flat container and drying it.

The following Examples and Experimental Examples are only illustrative of the present invention, and the scope of the present invention is not limited by the Examples and Experimental Examples.

<Example 1> Silk artificial brain dura

A silkworm cocoon was used as a sample and refined at 100 ° C. with Marise oil soap to remove sericin.

The refined silk was dissolved in calcium chloride, ethanol, and calcium chloride-alcohol-aqueous solution prepared in water 1: 2: 8 (molar ratio) at 80 ° C. for 20 minutes.

This aqueous silk solution was placed in a dialysis membrane (MWCO = 12,000) and dialyzed in distilled water for 3 days to remove salt and ethanol.

The final concentration of the silk fibroin solution produced was about 2.5% and concentrated using PEG 20,000 (polyethylene glycol) to a concentration of 7 ~ 8%.

Add 0.01 to 50.00% by weight of calcium chloride solution to 50.00 ~ 99.99% by weight of the concentrated silk fibroin solution and mix well using a stirrer. An artificial silk dura was prepared as an example of the present invention.

Experimental Example 1 Structural Characteristics and Physical Properties of Silk Artificial Brain Dural

The thickness of the artificial dura, which is an example of the present invention produced in Example 1, was measured using a thickness gauge, and the structure was observed by FT-IR analysis.

Surface and cross-sectional structures were observed using a scanning electron microscope (SEM).

Tensile strength and elongation at break of the silk artificial brain dura, which is an example of the present invention prepared in Example 1, were measured using a tensile strength tester.

Experimental Example 2 Cell Culture and Cytotoxicity Experiment

For cytotoxicity testing, L929 fibroblasts were purchased from ATCC and incubated for 24 hours after inoculation with 10,000 cells per well in MEM medium containing 10% bovine serum, 50 μg / ml streptomycin and 100 U / ml penicillin. It was.

The silk artificial brain dura, an example of the present invention prepared in Example 1, was cut into 1 × 1 cm, and 10 ml of medium was added to 1 g of the dural sample, and eluted in a 37 ° C. CO 2 incubator for 24 hours.

The eluted samples were serially diluted with media and then treated with pre-cultured cells, and cell viability was evaluated using the MTT method.

<Result 1> Production result of silk artificial brain dura

Silk brain dura mat made of only silk fibroin has transparency but strong thickness 300 micrometers or less. However, the silk artificial brain dura, which is an example of the present invention produced in Example 1, can be adjusted to a thickness of 300 μm or more, and even 500 μm or more.

In the case of producing a silk artificial brain dura using a conventional manufacturing method of the artificial brain dural with silk fibroin, when the silk artificial brain dura has a thickness of 300 μm or more, transparency, which is a strength, disappears, but the present invention maintains transparency and thick silk artificial brain dura Can be produced.

<Result 2> Structural Characteristics and Physical Properties of Silk Artificial Brain Dural

 Silk artificial brain dural, which is an example of the present invention produced in Example 1 has flexibility, elasticity and suture strength as shown in Table 1 and the graph of Fig. 1, the cross-sectional and surface photographic drawing of Figure 2 (pictured above) The cross section and the surface of the artificial brain film made using only silver silk, as shown in the cross-sectional view and the surface of the present invention below) has a smooth and uniform surface and cross-section while having a thickness of more than 300㎛.

In the case of the silk artificial brain dura, an example of the present invention, the elongation was greatly improved by 356.7%.

Load (N) Maximum Length (mm) Maximum elongation rate (%) Artificial brain dural control 42.4 2.96 14.8 Thick silk membrane of the present invention 55.8 71.34 356.7

In addition, as can be seen in Figures 3a and 3b, the silk artificial brain dura, an example of the present invention has transparency to enable safe treatment during cerebral neurosurgery surgery.

In addition, as can be seen in Figure 4, the silk artificial brain dura, an example of the present invention has considerable flexibility, and as shown in Figure 5 maintains a suitable suture strength during surgery.

<Result 3> Results of Cytotoxicity Test

As a result of the cytotoxicity test of calcium chloride and silk contained in the silk artificial brain membrane of the present invention prepared in Example 1, as shown in Figs. 6a to 6b, irrespective of the concentration of the silk artificial brain dura extract, 24, 48 and 72 hours Almost 100% survival rate.

This result indicates that calcium chloride as well as silk contained in the silk artificial brain dura, which is an example of the present invention, do not exhibit cytotoxicity.

Claims (7)

Prepared with a mixture of silk fibroin and salt,
The silk fibroin is 50.00 ~ 99.99% by weight, the salt is composed of 0.01 ~ 50.00% by weight,
Characterized in that it is made of a transparent membrane having a biocompatible and flexible and at the same time does not cause an inflammatory reaction,
Silk artificial film.
delete The method of claim 1,
The salt is a silk artificial film, characterized in that any one of calcium chloride, sodium chloride, potassium chloride, sodium acetate.
The silk artificial film of claim 1 or 3,
Characterized in that for artificial brain dural or biological membrane,
Silk artificial film.
50.00 to 99.99% by weight of silk fibroin is mixed with 0.01 to 50.00% by weight of a salt to make a mixed solution; And
Pouring the mixed solution in a flat container and dried to prepare a silk artificial film made of a transparent film having a biocompatibility and does not cause an inflammatory reaction and at the same time flexible;
Method for producing silk artificial membranes for artificial brain dural and biological membranes.
The method of claim 5,
The salt is characterized in that any one of calcium chloride, sodium chloride, potassium chloride, sodium acetate, method of producing a silk artificial membrane for artificial brain dural and biological membranes.
The method of claim 5,
In the drying step, the mixed solution contained in the container is dried in a constant temperature room containing 20 ~ 80 ℃, 20 ~ 80% moisture, artificial membranes and artificial membranes for the production of silk artificial membranes.
KR20100133134A 2010-12-23 2010-12-23 Silk artificial membrane for artificial dural membrane and biological membrane with excellent flexibility and solidity KR101322337B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR20100133134A KR101322337B1 (en) 2010-12-23 2010-12-23 Silk artificial membrane for artificial dural membrane and biological membrane with excellent flexibility and solidity
PCT/KR2011/009826 WO2012086988A2 (en) 2010-12-23 2011-12-20 Artificial silk membrane having excellent flexibility and suturing ability and method of manufacturing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20100133134A KR101322337B1 (en) 2010-12-23 2010-12-23 Silk artificial membrane for artificial dural membrane and biological membrane with excellent flexibility and solidity

Publications (2)

Publication Number Publication Date
KR20120071546A KR20120071546A (en) 2012-07-03
KR101322337B1 true KR101322337B1 (en) 2013-10-25

Family

ID=46314603

Family Applications (1)

Application Number Title Priority Date Filing Date
KR20100133134A KR101322337B1 (en) 2010-12-23 2010-12-23 Silk artificial membrane for artificial dural membrane and biological membrane with excellent flexibility and solidity

Country Status (2)

Country Link
KR (1) KR101322337B1 (en)
WO (1) WO2012086988A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200051077A (en) 2018-11-02 2020-05-13 오스젠 주식회사 Artificial dura membrane and their manufacturing methods using Melt Electrospinning

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103341214B (en) * 2013-07-08 2014-12-31 苏州大学 Silk fibroin membrane and preparation method thereof
CN107441498A (en) * 2017-06-12 2017-12-08 安徽省颍上县正泰电器有限责任公司 A kind of preparation method of the carbon nano-tube modified composite stone wax powder powder material of nano-cellulose
CN108396425A (en) * 2018-03-16 2018-08-14 青岛大学 A kind of fibroin albumen/carbon nanotube serialization filament yarn and preparation method thereof
CN111572983B (en) * 2020-04-26 2022-04-05 浙江天益塑业有限公司 Preparation method of high-strength degradable paper-plastic composite bag
CN112813007A (en) * 2021-02-23 2021-05-18 江苏科技大学 Method for repairing biological material film by biological template method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100121169A (en) * 2009-05-08 2010-11-17 한림대학교 산학협력단 Artificial eardrum using silk protein and method for fabricating the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100121169A (en) * 2009-05-08 2010-11-17 한림대학교 산학협력단 Artificial eardrum using silk protein and method for fabricating the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200051077A (en) 2018-11-02 2020-05-13 오스젠 주식회사 Artificial dura membrane and their manufacturing methods using Melt Electrospinning

Also Published As

Publication number Publication date
WO2012086988A3 (en) 2012-09-27
WO2012086988A9 (en) 2012-11-15
KR20120071546A (en) 2012-07-03
WO2012086988A2 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
Chouhan et al. Silk biomaterials in wound healing and skin regeneration therapeutics: From bench to bedside
KR101322337B1 (en) Silk artificial membrane for artificial dural membrane and biological membrane with excellent flexibility and solidity
CA2173546C (en) Medical materials and manufacturing methods thereof
US10219895B2 (en) Nanofiber-based graft for heart valve replacement and methods of using the same
Caves et al. The use of microfiber composites of elastin-like protein matrix reinforced with synthetic collagen in the design of vascular grafts
JP6648056B2 (en) Method for producing collagen membrane and use thereof
CN102188747A (en) Compound tissue engineering scaffold containing PLGA (poly(lactic-co-glycolic acid) strengthening net, and preparation method and application thereof
CN110041536A (en) Functional sericin hydrogel and its preparation method and application
KR101604584B1 (en) Composite comprising hydroxyapatite, chitosan or its derivative, and catechol or its derivative and use thereof
CN104771787A (en) Composite support containing PGA strengthening net, preparation method and applications thereof
Kweon et al. In vivo bone regeneration ability of different layers of natural silk cocoon processed using an eco-friendly method
EP3154600B1 (en) Artificial biomembrane using cocoon and method for manufacturing same
EP3476409A1 (en) Composite hydrogel for cell encapsulation comprising collagen and silk fibroin, and preparation method thereof
KR101602797B1 (en) Artificial biomembrane using silk matrix and Method for manufacturing thereof
CN106552294B (en) Biological patch material for heart repair
KR101380780B1 (en) Fabrication Method of Bilayer Scaffold For Skin Tissue
Srinivasan et al. Characterization of biocompatible collagen fibers—a promising candidate for cardiac patch
Noishiki Biochemical response to Dacron vascular prosthesis
Alves et al. Dense lamellar scaffold as biomimetic materials for reverse engineering of myocardial tissue: preparation, characterization and physiomechanical properties
Pillai et al. Tissue engineering of human knee meniscus using functionalized and reinforced silk-pva composite 3d scaffolds: Understanding the in vitro and in vivo behaviour
KR102077815B1 (en) Hydrogel composite including three-dimensional textile structure, and preparing method of the same
KR101182417B1 (en) Artificial Nanofiber Amnion Membranes and Method of Making The Same
KR101150826B1 (en) Artificial dura made from silk fibroin and producing method thereof
Grandi et al. ECM-based triple layered scaffolds for vascular tissue engineering
KR102182883B1 (en) Collagen Membrane and Method for Fabricating the Same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration
GRNT Written decision to grant